TRAMADOL/PARACETAMOL 37.5/325 APOTEX tramadol hydrochloride/paracetamol 37.5 mg/325 mg film-coated tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

tramadol hydrochloride, Quantity: 37.5 mg; paracetamol, Quantity: 325 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; macrogol 8000; hypromellose; hyprolose; stearic acid; titanium dioxide; croscarmellose sodium; iron oxide yellow; pregelatinised maize starch; povidone

Administration route:

Oral

Units in package:

6, 8, 10 Tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Tramadol/paracetamol is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Product summary:

Visual Identification: Yellow, capsule shaped, biconvex, film-coated tablet. Engraved APO on one side and 37.5 - 325 on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2018-02-22